We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
IDYA icon
201
IDEAYA Biosciences
IDYA
$3.48B
$3.48B $36.11 2.01%
ALMS
202
Alumis Inc
ALMS
$3.46B
$3.46B $27.12 3.83%
BKD icon
203
Brookdale Senior Living
BKD
$3.4B
$3.4B $14.23 0.97%
MBX
204
MBX Biosciences
MBX
$3.37B
$3.37B $70.70 9.77%
ARQT icon
205
Arcutis Biotherapeutics
ARQT
$3.26B
$3.26B $26.03 0.35%
NHC icon
206
National Healthcare
NHC
$3.25B
$3.25B $208.20 6.54%
NAMS icon
207
NewAmsterdam Pharma
NAMS
$3.22B
$3.22B $27.55 0.22%
GRAL
208
GRAIL Inc
GRAL
$3.12B
$3.12B $72.70 3.46%
CLDX icon
209
Celldex Therapeutics
CLDX
$3.07B
$3.07B $39.05 3.61%
QURE icon
210
uniQure
QURE
$3.03B
$3.03B $43.68 0.86%
PRVA icon
211
Privia Health
PRVA
$3B
$3B $23.79 0%
RGC icon
212
Regencell Bioscience
RGC
$2.99B
$2.99B $6.05 1.31%
IRON icon
213
Disc Medicine
IRON
$2.99B
$2.99B $77.80 1.95%
ACHC icon
214
Acadia Healthcare
ACHC
$2.95B
$2.95B $31.67 3.53%
BEAM icon
215
Beam Therapeutics
BEAM
$2.92B
$2.92B $28.35 9.42%
XRAY icon
216
Dentsply Sirona
XRAY
$2.86B
$2.86B $14.27 0.99%
IMNM icon
217
Immunome
IMNM
$2.84B
$2.84B $25.06 8.91%
ALHC icon
218
Alignment Healthcare
ALHC
$2.8B
$2.8B $13.52 7.14%
TMDX icon
219
Transmedics
TMDX
$2.79B
$2.79B $80.75 0.98%
ESTA icon
220
Establishment Labs
ESTA
$2.78B
$2.78B $94.61 1.95%
KOD icon
221
Kodiak Sciences
KOD
$2.68B
$2.68B $42.89 7.68%
TARS icon
222
Tarsus Pharmaceuticals
TARS
$2.67B
$2.67B $61.11 0.34%
TRVI icon
223
Trevi Therapeutics
TRVI
$2.66B
$2.66B $18.75 4.75%
ATAI icon
224
AtaiBeckley Inc
ATAI
$2.66B
$2.66B $7.18 0%
PLSE icon
225
Pulse Biosciences
PLSE
$2.64B
$2.64B $38.17 1.17%
7 8
9
10 11

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,066 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $8.94T.

The largest by market cap are Eli Lilly (LLY) at $995B, Johnson & Johnson (JNJ) at $614B and AbbVie (ABBV) at $431B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $8.94T across 1,066 stocks.
  • Largest constituent: Eli Lilly (LLY), $995B market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.